382 related articles for article (PubMed ID: 24949448)
21. Nanoparticles and the blood coagulation system. Part II: safety concerns.
Ilinskaya AN; Dobrovolskaia MA
Nanomedicine (Lond); 2013 Jun; 8(6):969-81. PubMed ID: 23730696
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles.
Pandey A; Mishra AK
BioTech (Basel); 2022 Sep; 11(3):. PubMed ID: 36134916
[TBL] [Abstract][Full Text] [Related]
23. Promoting Inter-/Intra- Cellular Process of Nanomedicine through its Physicochemical Properties Optimization.
Chen D; Wang J; Wang Y; Zhang F; Dong X; Jiang L; Tang Y; Zhang H; Li W
Curr Drug Metab; 2018; 19(1):75-82. PubMed ID: 29268683
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines.
Newton HS; Dobrovolskaia MA
Adv Drug Deliv Rev; 2022 Jun; 185():114281. PubMed ID: 35405297
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles in modern medicine: state of the art and future challenges.
Murthy SK
Int J Nanomedicine; 2007; 2(2):129-41. PubMed ID: 17722542
[TBL] [Abstract][Full Text] [Related]
26. Altered Cell Cycle Arrest by Multifunctional Drug-Loaded Enzymatically-Triggered Nanoparticles.
Huang C; Sun Y; Shen M; Zhang X; Gao P; Duan Y
ACS Appl Mater Interfaces; 2016 Jan; 8(2):1360-70. PubMed ID: 26698111
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles.
Panigaj M; Skelly E; Beasock D; Marriott I; Johnson MB; Salotti J; Afonin KA
Front Immunol; 2023; 14():1053550. PubMed ID: 36798121
[TBL] [Abstract][Full Text] [Related]
28. Bionanotechnology II: from biomolecular assembly to applications.
Cass T
IDrugs; 2009 Mar; 12(3):163-4. PubMed ID: 19333895
[No Abstract] [Full Text] [Related]
29. Theranostic Approach for the Protein Corona of Polysaccharide Nanoparticles.
Skalickova S; Horky P; Mlejnkova V; Skladanka J; Hosnedlova B; Ruttkay-Nedecky B; Fernandez C; Kizek R
Chem Rec; 2021 Jan; 21(1):17-28. PubMed ID: 33274843
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles: pharmacological and toxicological significance.
Medina C; Santos-Martinez MJ; Radomski A; Corrigan OI; Radomski MW
Br J Pharmacol; 2007 Mar; 150(5):552-8. PubMed ID: 17245366
[TBL] [Abstract][Full Text] [Related]
31. Breakthroughs in medicine and bioimaging with up-conversion nanoparticles.
Rostami I; Rezvani Alanagh H; Hu Z; Shahmoradian SH
Int J Nanomedicine; 2019; 14():7759-7780. PubMed ID: 31576121
[TBL] [Abstract][Full Text] [Related]
32. Molecular nanomedicine towards cancer: ¹¹¹In-labeled nanoparticles.
Psimadas D; Georgoulias P; Valotassiou V; Loudos G
J Pharm Sci; 2012 Jul; 101(7):2271-80. PubMed ID: 22488174
[TBL] [Abstract][Full Text] [Related]
33. Veterinary nanomedicine: Pros and cons.
Jafary F; Motamedi S; Karimi I
Vet Med Sci; 2023 Jan; 9(1):494-506. PubMed ID: 36580403
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-Based Modulation of the Immune System.
Fang RH; Zhang L
Annu Rev Chem Biomol Eng; 2016 Jun; 7():305-26. PubMed ID: 27146556
[TBL] [Abstract][Full Text] [Related]
35. Cerium oxide nanoparticles: applications and prospects in nanomedicine.
Das S; Dowding JM; Klump KE; McGinnis JF; Self W; Seal S
Nanomedicine (Lond); 2013 Sep; 8(9):1483-508. PubMed ID: 23987111
[TBL] [Abstract][Full Text] [Related]
36. Breaking Down the Barriers to Precision Cancer Nanomedicine.
von Roemeling C; Jiang W; Chan CK; Weissman IL; Kim BYS
Trends Biotechnol; 2017 Feb; 35(2):159-171. PubMed ID: 27492049
[TBL] [Abstract][Full Text] [Related]
37. New perspectives of nanoneuroprotection, nanoneuropharmacology and nanoneurotoxicity: modulatory role of amino acid neurotransmitters, stress, trauma, and co-morbidity factors in nanomedicine.
Sharma HS; Sharma A
Amino Acids; 2013 Nov; 45(5):1055-71. PubMed ID: 24022705
[TBL] [Abstract][Full Text] [Related]
38. Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications.
Zarschler K; Rocks L; Licciardello N; Boselli L; Polo E; Garcia KP; De Cola L; Stephan H; Dawson KA
Nanomedicine; 2016 Aug; 12(6):1663-701. PubMed ID: 27013135
[TBL] [Abstract][Full Text] [Related]
39. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicine and veterinary science: the reality and the practicality.
Underwood C; van Eps AW
Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
